Israel Castillo-Juárez

Dr. Israel Castillo-Juárez


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
VGVioleta González
Violeta González
HJHéctor Jaime-Aguilar
Héctor Jaime-Aguilar
GMGisela Martínez
Gisela Martínez
ELEdelmira Linares
Edelmira Linares
IRIrma Romero
Irma Romero

14 February 2017 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
VSValerie Soo
Valerie Soo
BKBrian Kwan
Brian Kwan
HQHéctor Quezada
Héctor Quezada
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
BPBerenice Pérez-Eretza
Berenice Pérez-Eretza
RGRodolfo García-Contreras
Rodolfo García-Contreras
Despite the fact that bacterial infections are one of the leading causes of death worldwide and that mortality rates are increasing at alarming rates, no new antibiotics have been produced by the pharmaceutical industry in more than a decade. The situation is so dire that the World Health Organization warned that we may enter a “post-antibiotic era” within this century; accordingly, bacteria resistant against all known antibiotics are becoming common and already producing untreatable infections. Although several novel approaches to combat bacterial infections have been proposed, they have yet to be implemented in clinical practice. Hence, we propose that a more plausible and faster approach is the utilization of drugs originally developed for other purposes besides antimicrobial activity. Among these are some anticancer molecules proven effective in vitro for eliminating recalcitrant, multidrug tolerant bacteria; some of which also protect animals from infections and recently are undergoing clinical trials. In this review, we highlight the similarities between cancer cells/tumors and bacterial infections, and present evidence that supports the utilization of some anticancer drugs, including 5-fluorouracil (5-FU), gallium (Ga) compounds, and mitomycin C, as antibacterials. Each of these drugs has some promising properties such as broad activity (all three compounds), dual antibiotic and antivirulence properties (5-FU), efficacy against multidrug resistant strains (Ga), and the ability to kill metabolically dormant persister cells which cause chronic infections (mitomycin C).

26 April 2022 in Plants
Verified
Journal Article
Open access
PDF file
MRMaría de la Luz Riviello-Flores
María de la Luz Riviello-Flores
JCJorge Cadena Cadena-Iñiguez
Jorge Cadena Cadena-Iñiguez
LRLucero M. Ruiz-Posadas
Lucero M. Ruiz-Posadas
MAMa. de Lourdes Arevalo-Galarza
Ma. de Lourdes Arevalo-Galarza
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
CCCarlos Roman Castillo-Martínez
Carlos Roman Castillo-Martínez
Agricultural biodiversity includes many species that have biological variants (natives, ecotypes, races, morphotypes). Their use is restricted to local areas because they do not fulfill the commercial requirements; however, it is well documented that these species are a source of metabolites, proteins, enzymes, and genes. Rescuing and harnessing them through traditional genetic breeding is time-consuming and expensive. Inducing mutagenesis may be a short-time option for its genetic improvement. A review of outstanding research was carried out, in order to become familiar with gene breeding using gamma radiation and its relevance to obtain outstanding agronomic characteristics for underutilized species. An approach was made to the global panorama of the application of gamma radiation in different conventional crop species and in vitro cultivated species, in order to obtain secondary metabolites, as well as molecular tools used for mutation screening. The varied effects of gamma radiation are essentially the result of the individual responses and phenotypic plasticity of each organism. However, even implicit chance can be reduced with specific genetic breeding, environmental adaptation, or conservation objectives.

1 October 2007 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
FRFausto Rivero-Cruz
Fausto Rivero-Cruz
HCHeliodoro Celis
Heliodoro Celis
IRIrma Romero
Irma Romero

1 October 2013 in Archives of Medical Research
Verified
Journal Article
Closed access
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
RGRodolfo García-Contreras
Rodolfo García-Contreras
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
MSMarcos Soto-Hernández
Marcos Soto-Hernández
MMMariano Martínez-Vázquez
Mariano Martínez-Vázquez

1 April 2019 in Microbiology
Verified
Journal Article
Closed access
MSMartín P. Soto-Aceves
Martín P. Soto-Aceves
MCMiguel Cocotl-Yañez
Miguel Cocotl-Yañez
EMEnrique Merino
Enrique Merino
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
HCHumberto Cortés-López
Humberto Cortés-López
Gloria Soberón-ChávezGloria Soberón-Chávez
Gloria Soberón-Chávez
Pseudomonas aeruginosa is an environmental bacterium but is also an opportunistic pathogen. The aim of this work is to evaluate the contribution of P. aeruginosa LasR and RhlR transcriptional regulators of the quorum-sensing response (QSR) to the production of virulence factors, and to its virulence in a mouse abscess model. The QSR is a complex regulatory network that modulates the expression of several virulence factors, including elastase, pyocyanin and rhamnolipids. LasR, when complexed with the auto-inducer 3-oxo-dodecanoyl lactone (3O-C12-HSL), produced by LasI, is at the top of the QSR regulatory cascade since it activates transcription of some genes encoding virulence factors (such as the gene coding for elastase, lasB) and also transcription of both rhlR and rhlI, encoding the synthase of the auto-inducer butanoyl-homoserine lactone (C4-HSL). In turn RhlR, coupled with C4-HSL, activates the transcription of genes encoding for the enzymes involved in pyocyanin and rhamnolipid production. Several efforts have been made to obtain inhibitors of LasR activity that would suppress the QSR. However, these attempts have used chemical compounds that might not be specific for LasR inactivation. In this work we show that individual inactivation of either lasR or rhlR did not block the QSR, nor did it impair P. aeruginosa virulence, and that even a lasR rhlR double mutant still presented residual virulence, even lacking the production of virulence factors. These results show that the inhibition of either lasR or rhlR is not a straightforward approach to blocking P. aeruginosa virulence, due to the great complexity of the QSR.